As of June 21, 2025, BIOLASE Inc (BIOL) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing BIOLASE Inc's Forward P/E to Peers
To better understand BIOLASE Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| BIOLASE Inc (BIOL) | - |
| Hamilton Thorne Ltd (HTL.V) | 352.94 |
| Delcath Systems Inc (DCTH) | 96.03 |
| Intuitive Surgical Inc (ISRG) | 63.67 |
| IDEXX Laboratories Inc (IDXX) | 42.32 |
| Dexcom Inc (DXCM) | 39.54 |
Compared to its competitors, BIOLASE Inc's Forward P/E is difficult to compare due to insufficient data.